Proteome Sciences plc (PMSNF)
USD 0.03
(7.14%)
USD 0.03
(7.14%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.26 Million USD | 0.12% |
| 2022 | 3.96 Million USD | 20.01% |
| 2021 | 3.3 Million USD | 19.72% |
| 2020 | 2.75 Million USD | -21.51% |
| 2019 | 3.51 Million USD | -14.72% |
| 2018 | 4.12 Million GBP | -23.76% |
| 2017 | 5.4 Million GBP | 3.59% |
| 2016 | 5.21 Million GBP | -15.44% |
| 2015 | 6.17 Million GBP | 24.7% |
| 2014 | 4.94 Million GBP | 0.66% |
| 2013 | 4.91 Million GBP | -1.84% |
| 2012 | 5 Million GBP | -1.89% |
| 2011 | 5.1 Million GBP | -0.52% |
| 2010 | 5.13 Million GBP | 5.4% |
| 2009 | 4.86 Million GBP | -0.67% |
| 2008 | 4.9 Million GBP | -7.96% |
| 2007 | 5.32 Million GBP | -11.76% |
| 2006 | 6.03 Million GBP | 2.46% |
| 2005 | 5.89 Million GBP | 34.9% |
| 2004 | 4.36 Million GBP | -30.73% |
| 2003 | 6.3 Million GBP | 61.1% |
| 2002 | 3.91 Million GBP | 92.0% |
| 2001 | 2.03 Million GBP | 67.87% |
| 2000 | 1.21 Million GBP | -3.34% |
| 1999 | 1.25 Million GBP | -37.39% |
| 1998 | 2 Million GBP | 19.55% |
| 1997 | 1.67 Million GBP | 2.88% |
| 1996 | 1.63 Million GBP | 0.0% |
| 1994 | 24 Thousand GBP | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.87 Million USD | 0.0% |
| 2023 Q2 | 2.44 Million USD | 0.0% |
| 2023 FY | 3.96 Million USD | 0.12% |
| 2023 Q4 | 1.7 Million USD | 0.0% |
| 2022 FY | 3.96 Million USD | 20.01% |
| 2022 Q2 | 1.86 Million USD | 0.0% |
| 2022 Q4 | 1.81 Million USD | 0.0% |
| 2021 FY | 3.3 Million USD | 19.72% |
| 2021 Q2 | 1.96 Million USD | 0.0% |
| 2021 Q4 | 1.52 Million USD | 0.0% |
| 2020 Q4 | 893.98 Thousand USD | 0.0% |
| 2020 FY | 2.75 Million USD | -21.51% |
| 2020 Q2 | 1.7 Million USD | 0.0% |
| 2019 Q4 | 1.91 Million USD | 0.0% |
| 2019 FY | 3.51 Million USD | -14.72% |
| 2019 Q2 | 1.53 Million USD | 0.0% |
| 2018 FY | 4.12 Million GBP | -23.76% |
| 2017 FY | 5.4 Million GBP | 3.59% |
| 2016 FY | 5.21 Million GBP | -15.44% |
| 2015 FY | 6.17 Million GBP | 24.7% |
| 2014 FY | 4.94 Million GBP | 0.66% |
| 2013 FY | 4.91 Million GBP | -1.84% |
| 2012 FY | 5 Million GBP | -1.89% |
| 2011 FY | 5.1 Million GBP | -0.52% |
| 2010 FY | 5.13 Million GBP | 5.4% |
| 2009 FY | 4.86 Million GBP | -0.67% |
| 2008 FY | 4.9 Million GBP | -7.96% |
| 2007 FY | 5.32 Million GBP | -11.76% |
| 2006 FY | 6.03 Million GBP | 2.46% |
| 2005 FY | 5.89 Million GBP | 34.9% |
| 2004 FY | 4.36 Million GBP | -30.73% |
| 2003 FY | 6.3 Million GBP | 61.1% |
| 2002 FY | 3.91 Million GBP | 92.0% |
| 2001 FY | 2.03 Million GBP | 67.87% |
| 2000 FY | 1.21 Million GBP | -3.34% |
| 1999 FY | 1.25 Million GBP | -37.39% |
| 1998 FY | 2 Million GBP | 19.55% |
| 1997 FY | 1.67 Million GBP | 2.88% |
| 1996 FY | 1.63 Million GBP | 0.0% |
| 1994 FY | 24 Thousand GBP | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -211.535% |
| Arrayit Corporation | 6.19 Million USD | 47.27% |
| Atlantic International Corp. | 5.57 Million USD | 41.416% |
| Biocept, Inc. | 29.4 Million USD | 88.885% |
| Bioqual, Inc. | 7.44 Million USD | 56.127% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -323.238% |
| DermTech, Inc. | 104.01 Million USD | 96.858% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 98.037% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 85.555% |
| iMD Companies, Inc. | 151.8 Thousand USD | -2052.705% |
| IDenta Corp. | 662.97 Thousand USD | -392.93% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 83.847% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -8305.134% |
| InVitro International | 661.32 Thousand USD | -394.16% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | 53.959% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -5523.623% |
| Medical Imaging Corp. | 1.91 Million USD | -70.906% |
| NovelStem International Corp. | 3.53 Million USD | 7.626% |
| Optigenex Inc. | 1.28 Million USD | -153.753% |
| PharmChem, Inc. | 2.93 Million USD | -11.489% |
| Response Genetics, Inc | 25.31 Million USD | 87.093% |
| Rennova Health, Inc. | 7.67 Million USD | 57.436% |
| RushNet, Inc. | 1.78 Million USD | -82.639% |
| ScreenPro Security Inc. | 3.23 Million USD | -0.898% |
| Stella Diagnostics Inc. | 11.42 Million USD | 71.401% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | 55.495% |
| Todos Medical Ltd. | 14.05 Million USD | 76.753% |